Translational Bioinformatics: Past, Present, and Future
暂无分享,去创建一个
[1] Gabi Kastenmüller,et al. Biochemical insights from population studies with genetics and metabolomics. , 2016, Archives of biochemistry and biophysics.
[2] Jessica D. Tenenbaum,et al. An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective , 2012, Journal of personalized medicine.
[3] William Pao,et al. Enabling a genetically informed approach to cancer medicine: a retrospective evaluation of the impact of comprehensive tumor profiling using a targeted next-generation sequencing panel. , 2014, The oncologist.
[4] Justin Lamb,et al. The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.
[5] J. Foster,et al. Gut–brain axis: how the microbiome influences anxiety and depression , 2013, Trends in Neurosciences.
[6] Rowena J Dolor,et al. The MURDOCK Study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. , 2012, American journal of translational research.
[7] Oznur Tastan,et al. Integromic Analysis of Genetic Variation and Gene Expression Identifies Networks for Cardiovascular Disease Phenotypes , 2015, Circulation.
[8] Leif C. Groop,et al. Genotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist , 2014, Science Translational Medicine.
[9] LeighAnne Olsen,et al. Leadership Commitments to Improve Value in Health Care: Finding Common Ground: Workshop Summary , 2009 .
[10] Francis S. Collins,et al. PCORnet: turning a dream into reality , 2014, J. Am. Medical Informatics Assoc..
[11] Jeanette J McCarthy,et al. Genomic Medicine: A Decade of Successes, Challenges, and Opportunities , 2013, Science Translational Medicine.
[12] Francis S. Collins,et al. Bringing the Common Rule into the 21st Century. , 2015, The New England journal of medicine.
[13] E. Mardis. The $1,000 genome, the $100,000 analysis? , 2010, Genome Medicine.
[14] J. Frankovich,et al. Evidence-based medicine in the EMR era. , 2011, The New England journal of medicine.
[15] Isaac S Kohane,et al. The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine , 2014, Trials.
[16] E. Schadt. The changing privacy landscape in the era of big data , 2012, Molecular systems biology.
[17] Robert Cook-Deegan,et al. Disclosure of APOE genotype for risk of Alzheimer's disease. , 2009, The New England journal of medicine.
[18] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[19] Shankar Baskar,et al. Genotype-phenotype correlation in long QT syndrome , 2015, Global cardiology science & practice.
[20] Fernando Martin-Sanchez,et al. Translational Bioinformatics , 2021, Biomedical Informatics.
[21] Mårten Fryknäs,et al. Repositioning of the anthelmintic drug mebendazole for the treatment for colon cancer , 2013, Journal of Cancer Research and Clinical Oncology.
[22] Cui Tao,et al. Exploring the Pharmacogenomics Knowledge Base (PharmGKB) for Repositioning Breast Cancer Drugs by Leveraging Web Ontology Language (OWL) and Cheminformatics Approaches , 2013, Pacific Symposium on Biocomputing.
[23] Erika Check Hayden. Out of regulatory limbo, 23andMe resumes some health tests and hopes to offer more , 2015 .
[24] Bryan R Luce,et al. Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change , 2009, Annals of Internal Medicine.
[25] Yan Zhang,et al. Integrated systems approach identifies risk regulatory pathways and key regulators in coronary artery disease , 2015, Journal of Molecular Medicine.
[26] Philip R. O. Payne,et al. Evidence generating medicine: redefining the research-practice relationship to complete the evidence cycle. , 2013, Medical care.
[27] Nikhil Wagle,et al. Response and acquired resistance to everolimus in anaplastic thyroid cancer. , 2014, The New England journal of medicine.
[28] J C Denny,et al. Surveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal Genomics , 2014, Yearbook of Medical Informatics.
[29] Euan A Ashley,et al. Clinical interpretation and implications of whole-genome sequencing. , 2014, JAMA.
[30] Joseph L DeRisi,et al. Actionable diagnosis of neuroleptospirosis by next-generation sequencing. , 2014, The New England journal of medicine.
[31] F. Collins,et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits , 2009, Proceedings of the National Academy of Sciences.
[32] N. Shah,et al. A 'green button' for using aggregate patient data at the point of care. , 2014, Health affairs.
[33] Melissa Haendel,et al. A sea of standards for omics data: sink or swim? , 2013, J. Am. Medical Informatics Assoc..
[34] T. Insel,et al. Brain disorders? Precisely , 2015, Science.
[35] Russ B Altman,et al. PharmGKB: a logical home for knowledge relating genotype to drug response phenotype , 2007, Nature Genetics.
[36] Gerard Tromp,et al. Design patterns for the development of electronic health record-driven phenotype extraction algorithms , 2014, J. Biomed. Informatics.
[37] Shelley A. Rusincovitch,et al. A comparison of phenotype definitions for diabetes mellitus. , 2013, Journal of the American Medical Informatics Association : JAMIA.
[38] G. Hartvigsen,et al. Secondary Use of EHR: Data Quality Issues and Informatics Opportunities , 2010, Summit on translational bioinformatics.
[39] Alexander A. Morgan,et al. Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data , 2011, Science Translational Medicine.
[40] Rong Chen,et al. Finding Disease-Related Genomic Experiments Within an International Repository: First Steps in Translational Bioinformatics , 2006, AMIA.
[41] Rachael Fleurence,et al. How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda. , 2013, Health affairs.
[42] Jennifer G. Robinson,et al. Electronic health records based phenotyping in next-generation clinical trials: a perspective from the NIH Health Care Systems Collaboratory. , 2013, Journal of the American Medical Informatics Association : JAMIA.
[43] Eran Halperin,et al. Identifying Personal Genomes by Surname Inference , 2013, Science.
[44] Zhiyong Lu,et al. A survey of current trends in computational drug repositioning , 2016, Briefings Bioinform..
[45] Marylyn D. Ritchie,et al. Phenome-Wide Association Study (PheWAS) for Detection of Pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) Network , 2013, PLoS genetics.
[46] M. Ritchie,et al. Phenome-Wide Association Studies: Leveraging Comprehensive Phenotypic and Genotypic Data for Discovery , 2015, Current Genetic Medicine Reports.
[47] Thomas A. Ban,et al. The role of serendipity in drug discovery , 2006, Dialogues in clinical neuroscience.
[48] Melissa A. Basford,et al. Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. , 2011, American journal of human genetics.
[49] J. Cubells,et al. The Gut Microbiome: A New Frontier in Autism Research , 2013, Current Psychiatry Reports.
[50] A. Butte,et al. A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. , 2013, Cancer discovery.
[51] Ron Milo,et al. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans , 2016, Cell.
[52] C. Chute,et al. Electronic Medical Records for Genetic Research: Results of the eMERGE Consortium , 2011, Science Translational Medicine.
[53] Khader Shameer,et al. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification. , 2015, Current topics in medicinal chemistry.